Lifirafenib

CAS : 1446090-79-4

Ref. 3D-WHC09079

Informations sur le produit

• Nom: Lifirafenib
• CAS: 1446090-79-4

Description

Lifirafenib is a potent, selective and orally bioavailable, small-molecule inhibitor of the kinase activity of CDK4/6. It has potent antitumor activity in mutant melanoma xenografts that is mediated by the inhibition of epidermal growth factor receptor (EGFR) signaling. Lifirafenib also inhibits EGFR signaling in human CD4+ cells and has anti-inflammatory properties. This drug has shown to be effective against inflammatory diseases such as lupus nephritis, rheumatoid arthritis, and psoriatic arthritis. Lifirafenib is being repositioned for treatment of hematologic malignancies including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 478.42 g/mol
• Formule: C₂₅H₁₇F₃N₄O₃
• Degré de pureté: Min. 95%